What we do
Since 2002, as a contract research and development organization, we offer to our customers:
- Custom-made formulation and complex generic development
- Quality control and ICH stability, analytical development and validations
- Production assistance
The labs are equipped for the design, control and stability studies of solid dosage forms as well as liquid and semi-solid dosage forms.
January 2017. Unither Pharmaceuticals and Aptys Pharmaceuticals start the development of an innovative product to treat moderate to severe pain
« We are delighted to collaborate with Aptys Pharmaceuticals, a company well-known in the field of innovative formulation development » declares Eric Goupil, President and CEO of Unither Pharmaceuticals.
« We are very pleased with this partnership with Unither Pharmaceuticals which will bring all its experience in pharmaceutical, clinical and regulatory development» adds François Boutignon, President and CEO of Aptys Pharmaceuticals.
phone: +33 473 670 670
F-63360 Saint Beauzire, France